YTE reported $21.3M in Stock for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Stock Change
Acadia Pharmaceuticals ACAD:US $ 14.34M 3.55M
Alnylam Pharmaceuticals ALNY:US $ 110.95M 26.59M
Amgen AMGN:US $ 4152M 37M
Biocryst Pharmaceuticals BCRX:US $ 13.66M 3.82M
Biogen BIIB:US $ 1347.9M 93.1M
Biomarin Pharmaceutical BMRN:US $ 749.41M 38.43M
Bluebird Bio BLUE:US $ 0.77M 12.74M
Bristol Myers Squibb BMY:US $ 2163M 26M
Clovis Oncology CLVS:US $ 17.28M 7.72M
Eli Lilly And LLY:US $ 3907.4M 82.5M
Exelixis EXEL:US $ 28.24M 3.26M
Gilead Sciences GILD:US $ 2797M 191M
IONIS PHARMACEUT IONS:US $ 22.93M 1.17M
Nektar Therapeutics NKTR:US $ 15.33M 0.71M
Neurocrine Biosciences NBIX:US $ 25.5M 2.8M
Novartis NOVN:VX SF 6885M 226M
Ptc Therapeutics PTCT:US $ 15.61M 0.83M
Puma Biotechnology PBYI:US $ 7.21M 0.41M
Regeneron Pharmaceuticals REGN:US $ 1550.1M 433.8M
Seattle Genetics SGEN:US $ 181.38M 18.19M
Ultragenyx Pharmaceutical RARE:US $ 15.19M 0.11M
Vertex Pharmaceuticals VRTX:US $ 333.46M 11.84M
YTE INCY:US $ 21.3M 4.63M